McKinsey is negotiating a deferred prosecution agreement with the DOJ to resolve allegations of facilitating opioid sales, expected to involve over $600m in settlements.
The ongoing negotiations with the US Department of Justice could lead to the dismissal of criminal charges against McKinsey, dependent on compliance with the settlement terms.
McKinsey has previously faced significant legal actions and settlements totaling nearly $1bn for its role in advising Purdue Pharma and other opioid manufacturers.
The company has neither admitted liability nor wrongdoing in its settlements, maintaining an ongoing discussion about its past conduct related to the opioid crisis.
Collection
[
|
...
]